PI Industries Limited

PI Industries Limited

PIIND.BO
PI Industries LimitedIN flagBombay Stock Exchange
2,677.30
INR
+23.30
- -
406.05BMarket Cap
PI Industries Limited
PIIND.BO
(Bombay Stock Exchange)

Recent

price

2,677.30

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
64.62
14.05
90.26
116.78
142.05
151.69
163.45
163.16
202.4
239.55
305.61
349.51
425.79
501.78
525.89
442.53
442.59
Revenue per Share
5.86
1.66
7.65
13.84
18.03
22.77
33.46
26.72
29.74
33.08
49.92
55.65
81.06
110.85
109.44
87.06
87.07
Basic EPS, GAAP
-6.85
-0.2
8.02
16.12
13.5
26.81
24.67
23.22
28.33
1.74
19.33
12.64
77.47
93.31
37.11
-42.44
- -
Free Cash Flow per Basic Share
0.13
0.16
0.59
2
2.2
5.3
1.81
4.81
6.02
5.42
4.1
5
7.5
11.5
15
15.02
- -
Dividend per Share
1.74
3.64
23.61
32.24
45.12
61.13
88.91
110.74
135.71
163.2
198.26
244.05
311.35
408.83
504.75
1
1
Book Value per Share
19.08
5.13
41.21
50.32
66.17
84.3
116.57
137.88
163.13
178.35
350.64
392.43
462.66
530.81
599.9
660.08
660.17
Tangible Book Value per Share
111
624
127
136
136
137
137
138
138
138
148
152
152
152
152
152
152
Basic Weighted Avg Shares
7,177
8,770
11,484
15,869
19,370
20,756
22,446
22,446
27,920
33,066
45,200
52,995
64,582
76,116
79,778
67,137
67,137
Sales/Revenue/Turnover
15.32
15.22
14.03
16.64
17.17
18.35
21.48
18.4
17.44
17.63
18.79
17.75
20.61
22.87
23.43
19.74
19.74
Operating Margin (%)
157
173
220
316
498
543
730
830
930
1,367
1,748
2,018
2,265
3,082
3,525
4,066
4,066
Depreciation Expense
651
1,036
973
1,880
2,459
3,116
4,594
3,676
4,102
4,566
7,383
8,438
12,295
16,815
16,602
13,208
13,208
Net Income, GAAP
28.77
27.77
32.88
28.05
30.78
22.66
9.83
21.03
23.74
25.61
21.33
18.3
14.87
11.25
22.49
22.13
22.13
Effective Tax Rate (%)
9.07
11.81
8.48
11.85
12.69
15.01
20.47
16.38
14.69
13.81
16.33
15.92
19.04
22.09
20.81
19.67
19.67
Profit Margin (%)
78
899
1,319
2,251
2,621
3,647
6,666
8,481
8,794
9,082
32,361
36,157
44,805
49,679
52,245
57,180
57,180
Working Capital
590
1,191
851
501
167
1,224
830
463
99
4,312
2,858
1,980
324
1,055
1,237
2,212
2,212
LT Debt
2,137
3,254
5,317
6,945
9,165
11,709
16,272
19,248
22,854
26,191
53,424
61,204
71,985
87,310
101,570
112,305
112,305
Total Equity
27.14
22.87
16.43
24.37
24.92
25.03
28.5
17.53
17.3
15.94
15.15
12.74
16.61
19.18
15.14
9.44
9.09
Return on Invested Capital (%)
61.25
42.48
22.41
36.37
39.1
37.08
39.99
25.21
23.46
19.84
24.83
23.33
28.71
30.61
23.69
32.53
433.75
Return on Capital (%)
277.19
83.96
36.88
50.92
46.69
42.92
44.66
26.79
24.16
22.14
28.48
25.44
29.19
30.78
23.96
34.43
8,689.47
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
603
- -
1,211
LT Borrowings
1,400
- -
1,490
LT Finance Leases
419
- -
722
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
152
- -
152
Market Capitalization
533,395
490,849
412,327

Working Capital

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
79,802
- -
74,947
Cash, Cash Equivalents & STI
39,177
- -
35,418
Accounts Receivable, Net
16,054
- -
16,108
Inventories
12,125
- -
12,167
Total Current Liabilities
19,696
- -
17,767
Payables & Accruals
- -
- -
- -
ST Debt
603
- -
1,211
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
27.49%
16.07%
10.57%
Free Cash Flow
123.26%
45.24%
-214.37%
Net Income, GAAP
18.71%
15.01%
-20.44%
Sales/Revenue/Turnover
- -
9.19%
-15.85%
Total Cash Common Dividend
25.63%
31.77%
0.13%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
19,104
21,169
18,975
16,868
76,116
2025
20,689
22,210
19,008
17,871
79,778
2026
19,005
18,723
13,757
15,652
67,137

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
25.24
31.67
29.59
- -
110.85
2025
29.59
33.51
24.55
21.79
109.44
2026
26.37
26.98
20.52
13.2
87.06

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
11.5
2025
- -
- -
- -
- -
15
2026
- -
- -
- -
- -
15.02
Business
PI Industries Limited (PIIND.BO), founded in 1946 and headquartered in Udaipur, Rajasthan, with corporate offices in Gurugram, Haryana, operates as a leading agrisciences company focused on crop protection and life sciences solutions; it manufactures and markets agrochemicals including insecticides such as Cosko, Osheen Ultra, Distruptor, and Dinoace, herbicides like Melsa, Eketsu, and Provide, fungicides including Fender, Defensa, and Sectin, plant growth regulators, biostimulants such as Tomatough, Aminogrow, and Biovita X seaweed extract granules, and specialty fertilizers; through its Custom Synthesis & Manufacturing (CSM) segment, it provides contract research, development, and manufacturing services for agrochemicals, pharmaceuticals, electronic chemicals, and performance chemicals to global innovator companies in Japan, Germany, China, and the US; PI Health Sciences delivers end-to-end CRDMO services in pharmaceuticals backed by scientific platforms in chemistry and biologicals. The company maintains manufacturing facilities in Panoli and Jambusar, Gujarat, Jammu, and formulation units, with R&D centers in Udaipur featuring AI-discovered molecules, patented platforms, and over 500 scientists including PhDs; it operates a global footprint across more than 80 countries with overseas offices in China, Germany, Japan, the US, and subsidiaries including PI Health Sciences Netherlands B.V., Archimica S.p.A., PI Kumiai Pvt. Ltd., and step-down subsidiary Plant Health Care Plc in the UK with operations in Brazil, Mexico, Spain, and the US; primary markets include domestic farmers via a network of distributors and retail outlets targeting crops like cotton, rice, chili, horticulture, and wheat, alongside exports representing a significant revenue portion. Recent developments include the acquisition of UK-based Plant Health Care Plc in August 2024 for approximately ₹358 crore through its subsidiary PI Industries Management Consultancies L.L.C., enabling integrated chemical and biological agri-solutions and expanding biologicals capabilities; in FY2024-25, it launched seven new AgChem and horticultural products—PRESSEDO, SOLJU GR and SP, Osheen Ultra, DORITO, KAPRIGIN, BYROCK, and Vachan; the company divested its polymer compounding business, completed expansions of CSM facilities with two new multi-purpose plants in Panoli, advanced digital transformation with AI-driven discovery, SAP EHS, and analytics platforms, and commercialized new molecules including electronic chemicals while enhancing sustainability through water recycling exceeding 113 million liters annually, 100% recycled packaging, and renewable energy comprising 6.60% of total use.